Is Crinetics Pharma Stock a Buy?
Crinetics Pharmaceuticals (NASDAQ:CRNX) has had an extremely volatile year, ranging from a 52-week low of $24.10 to a high of $62.53. The stock, now trading …
Crinetics Pharmaceuticals (NASDAQ:CRNX) has had an extremely volatile year, ranging from a 52-week low of $24.10 to a high of $62.53. The stock, now trading …
Dentsply Sirona (NASDAQ:XRAY) is a large manufacturer of dental equipment and supplies that came into existence as the result of a 2016 merger between Dentsply …
When a once‑sleepy medical‑supplies house suddenly sells a crown‑jewel division, pays down billions of dollars in debt, and begins talking about …
When CoreWeave (NASDAQ: CRWV) slipped below its $40 IPO price earlier this year, skeptics wrote it off as an over-hyped AI play. Three months later the stock …
Few large‑cap health‑care names have experienced a reputational whiplash quite like Baxter International (NYSE: BAX). The medical‑technology …
Coherent (NYSE: COHR) has spent the better part of two years digging itself out of a post‑merger funk. All through 2023 and 2024 the share price chopped …
Altria Group (NYSE: MO) is paying investors $1.02 a share every quarter, or $4.08 a year. At the recent price of $59.75, that works out to a 6.8% yield, …
In Q1, Ken Griffin’s Citadel Advisors purchased nearly 1.3 million shares of health-oriented QSR Sweetgreen (NYSE:SG), adding to a position that …